dulaglutide to semaglutide conversion versus once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial Comparative effectiveness of semaglutide and

Ozempic is the 4 th once-weekly glucagon like peptide-1 receptor agonist (GLP-1 RA) medication to enter the market after Bydureon (exenatide extended release), Trulicity (dulaglutide), and Tanzeum (albiglutide)

GLP-1 medications do this by mimicking the GLP-1 hormone in the gut

Unadjusted Kaplan-Meier curves illustrate distinct cumulative incidence trajectories between the stratified subgroups in the Southern UK (left) and Northern UK (right) cohorts

Others are "slow and steady" types who notice gradual improvements over several weeks

In Idaho, semaglutide can be prescribed by professionals with the titles MD

Some see faster progress with the other